{"ref-id":"F3133","title":"Valsartan Canadian Monograph","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/133/original/Valsartan_HCT_TAB_Monograph.pdf?1548371352","parent_key":"BE0001004"}
{"ref-id":"F3139","title":"Valsartan HCT Canadian Monograph","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/139/original/Valsartan_HCT_TAB_Monograph.pdf?1548434624","parent_key":"BE0001069"}
{"ref-id":"F3070","title":"In Vitro and In Vivo Evidence of the Importance of Organic Anion Transporters (OATs) in Drug Therapy","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/070/original/e07ffe42a4c1adff0f22a11ef6e4047ac722.pdf?1548266696","parent_key":"BE0001066"}
{"ref-id":"F3103","title":"Interaction of Cytochrome P450 3A Inhibitors with P-Glycoprotein","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/103/original/4f94dab398541f1eecaf46307e8a349ea806.pdf?1548347447","parent_key":"BE0001032"}
{"ref-id":"F3106","title":"Identification, Ki determination and CoMFA analysis of nuclear receptor ligands as competitive inhibitors of OATP1B1-mediated estradiol-17N2-glucuronide transport","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/106/original/hagenbuch_identification.pdf?1548347962","parent_key":"BE0001004"}
{"ref-id":"F4411","title":"Delayed Elimination of Methotrexate Associated with Co-Administration of Proton Pump Inhibitors","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/411/original/MTX_co-administration_with_PPIs.pdf?1555452557","parent_key":"BE0001067"}
{"ref-id":"F4157","title":"Comparative Pharmacology of the H1 Antihistamines","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/157/original/Comparative_Pharmacology_of_H1_Antihistamines.pdf?1553808248","parent_key":"BE0001032"}
{"ref-id":"F873","title":"A Chemical Approach Towards Understanding the Mechanism and Reversal of Drug Resistance in Plasmodium falciparum: Is it Viable?","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/873/original/15216540212655.pdf?1532972576","parent_key":"BE0001032"}
{"ref-id":"F2103","title":"Pemetrexed FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/103/original/021462s050lbl.pdf?1543427978","parent_key":"BE0003645"}
{"ref-id":"F4223","title":"Tegaserod 2019 FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/223/original/021200Orig1s015lbl.pdf?1554242756","parent_key":"BE0001067"}
{"ref-id":"F4223","title":"Tegaserod 2019 FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/223/original/021200Orig1s015lbl.pdf?1554242756","parent_key":"BE0001032"}
{"ref-id":"F445","title":"Votubia, INN:EVEROLIMUS - European Medicines Agency - europa.eu","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/445/original/WC500135711.pdf?1530897834","parent_key":"BE0001004"}
{"ref-id":"F445","title":"Votubia, INN:EVEROLIMUS - European Medicines Agency - europa.eu","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/445/original/WC500135711.pdf?1530897834","parent_key":"BE0003659"}
{"ref-id":"F448","title":"AstraZeneca: AZD5847 Oxazolidinone for the treatment of Tuberculosis","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/448/original/CPTR_DAY2_0820_01_SCOTT-BUTLER.pdf?1530898958","parent_key":"BE0001004"}
{"ref-id":"F2193","title":"Xarelto FDA","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/193/original/Xarelto_FDA.pdf?1544546577","parent_key":"BE0001032"}
{"ref-id":"F2192","title":"Xarelto FDA","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/192/original/Xarelto_FDA.pdf?1544546559","parent_key":"BE0001067"}
{"ref-id":"F2197","title":"Apixaban FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/197/original/Apixaban_FDA_label.pdf?1544547199","parent_key":"BE0001032"}
{"ref-id":"F4316","title":"FDA label, Invokana","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/316/original/Invokana_FDA_label.pdf?1554933115","parent_key":"BE0001032"}
{"ref-id":"F4313","title":"Invokana, Canadian monograph","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/313/original/Invokana__Canadian_monograph.pdf?1554913610","parent_key":"BE0001032"}
{"ref-id":"F4313","title":"Invokana, Canadian monograph","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/313/original/Invokana__Canadian_monograph.pdf?1554913610","parent_key":"BE0001069"}
{"ref-id":"F4313","title":"Invokana, Canadian monograph","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/313/original/Invokana__Canadian_monograph.pdf?1554913610","parent_key":"BE0001067"}
{"ref-id":"F2566","title":"Harvoni FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/566/original/Harvoni_FDA_label.pdf?1546894276","parent_key":"BE0001032"}
{"ref-id":"F4304","title":"IBRANCE (palbociclib) FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/304/original/fda.pdf?1554762327","parent_key":"BE0001032"}
{"ref-id":"F4304","title":"IBRANCE (palbociclib) FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/304/original/fda.pdf?1554762327","parent_key":"BE0001067"}
{"ref-id":"F2125","title":"Australian Product Information, Venetoclax","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/125/original/Product_information__Australia__for_Venetoclax.pdf?1543868830","parent_key":"BE0001032"}
{"ref-id":"F2127","title":"Venclexta FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/127/original/Venclexta_FDA_label.pdf?1543869212","parent_key":"BE0001032"}
{"ref-id":"F2126","title":"Venclexta FDA label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/126/original/Venclexta_FDA_label.pdf?1543869141","parent_key":"BE0001067"}
{"ref-id":"F2128","title":"FDA label, Venclexta","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/128/original/Venclexta_FDA_label.pdf?1543869238","parent_key":"BE0001067"}
{"ref-id":"F2129","title":"FDA label, Venclexta","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/129/original/Venclexta_FDA_label.pdf?1543869260","parent_key":"BE0001004"}
{"ref-id":"F458","title":"Medicines.org: SUNVEPRAB. asunaprevir PRODUCT INFORMATION","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/458/original/bqpsunve.pdf?1530911353","parent_key":"BE0001004"}
{"ref-id":"F458","title":"Medicines.org: SUNVEPRAB. asunaprevir PRODUCT INFORMATION","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/458/original/bqpsunve.pdf?1530911353","parent_key":"BE0003659"}
{"ref-id":"F458","title":"Medicines.org: SUNVEPRAB. asunaprevir PRODUCT INFORMATION","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/458/original/bqpsunve.pdf?1530911353","parent_key":"BE0001042"}
{"ref-id":"F2172","title":"FDA label Sofusbuvir and Velpatasvir","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/172/original/Soforsbuvir_and_Velpatasvir_FDA_label.pdf?1544207805","parent_key":"BE0001032"}
{"ref-id":"F114","title":"European Medicines Agency (EMA): Assessment report on Curcuma xanthorrhiza Roxb. (C. xanthorrhiza D. Dietrich)., rhizoma","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/114/original/WC500144564.pdf?1527261710","parent_key":"BE0001032"}
{"ref-id":"F2120","title":"Sarecycline FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/120/original/209521s000lbl.pdf?1543531668","parent_key":"BE0001032"}
{"ref-id":"F4402","title":"Erdafitinib FDA Label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/402/original/212018s000lbl.pdf?1555368103","parent_key":"BE0001032"}
{"ref-id":"F2060","title":"Galliprant (Grapiprant) FDA veterinary label","url":"//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/060/original/20180605_a38cc5c6-93e8-4c90-aabc-33bc8423beab.pdf?1542915905","parent_key":"BE0001032"}